01—Abstract
Summary
Summary of the 8-K filed November 6, 2025. Cited figures are marked; the original filing is the authoritative source.
Cardinal Health, Inc. (CAH) has filed an 8-K reporting the results of its 2025 Annual Meeting of Shareholders, held on November 5, 2025.
The meeting primarily focused on shareholder votes concerning the Board of Directors, executive compensation, and the ratification of the independent auditor. All 12 director nominees were overwhelmingly elected, indicating strong shareholder confidence in the current board's leadership and strategic direction. The company also received a positive advisory vote on executive compensation, reflecting shareholder approval of the compensation packages for its named executive officers.
Furthermore, shareholders ratified the appointment of Ernst & Young LLP as the independent auditor for the upcoming fiscal year. This outcome suggests a stable governance environment and continued support for the company's financial oversight. Investors should view these results as indicators of continued operational and strategic stability within Cardinal Health.
02—Key points
Key Highlights
- All 12 director nominees were elected to the Board of Directors with significant 'For' votes, indicating strong shareholder confidence.
- The advisory vote on executive compensation ('say-on-pay') was approved, with a substantial majority of shareholders voting in favor.
- Ernst & Young LLP was ratified as the independent auditor for the fiscal year ending June 30, 2026, with overwhelming shareholder approval.
- The director election results show high levels of support, with most nominees receiving over 185 million 'For' votes.
- Broker non-votes were present for the director and executive compensation proposals, but not for the auditor ratification, indicating a majority of shares represented were in favor of the auditor.
- The outcomes suggest shareholder alignment with the company's current governance and financial reporting practices.
03—Questions
Frequently Asked Questions
What was the primary purpose of this 8-K filing?
This 8-K filing reports the results of Cardinal Health, Inc.'s 2025 Annual Meeting of Shareholders, specifically detailing the outcomes of shareholder votes on the election of directors, an advisory vote on executive compensation, and the ratification of the independent auditor.
How did shareholders vote on the election of the Board of Directors?
Shareholders overwhelmingly elected all 12 nominated directors to the Board of Directors. The voting results show strong support for each nominee, with 'For' votes significantly outnumbering 'Against' and 'Abstained' votes.
Was there shareholder approval for the executive compensation packages?
Yes, shareholders approved, on a non-binding advisory basis, the compensation of the Company's named executive officers. The 'say-on-pay' vote received a substantial majority of 'For' votes.
Who will serve as Cardinal Health's independent auditor for the upcoming fiscal year, and did shareholders ratify this appointment?
Ernst & Young LLP was ratified as the Company's independent auditor for the fiscal year ending June 30, 2026. The shareholder vote to ratify this appointment was overwhelmingly in favor.
04—Continue